EU medicines policy shift "sensible", says industry commissioner-designate
This article was originally published in Scrip
Executive Summary
Many people have protested about plans to return responsibility for medicines policy to the European Commission's enterprise directorate (DG ENTR), but the commissioner-designate for industry, entrepreneurship and the internal market, El?bieta Bie?kowska, is not one of them.